Revolution Medicines
(NASDAQ:RVMD)
$36.43
0[0.00%]
Last update: 4:20PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Revolution Medicines Stock (NASDAQ:RVMD), Quotes and News Summary

Revolution Medicines Stock (NASDAQ: RVMD) stock price, news, charts, stock research, profile.

Open$36.450
Close-
Volume / Avg.939.521K / 1.436M
Day Range36.170 - 37.870
52 Wk Range15.440 - 38.730
Market Cap$6.000B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
62
Short Interest
7.56%
Days to Cover9.04

Recent News

Top 3 Health Care Stocks That May Collapse In Q2
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Avi Kapoor
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share.
Avi Kapoor
What's Going On With Revolution Medicines Stock?
Revolution Medicines announced the publication of a peer-reviewed research paper in "Cancer Discovery" detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday. The company also announced the publication of two peer-reviewed research papers in "Nature" Tuesday. The first paper highlights the discovery and preclinical characterization of RMC-7977, and the second paper highlights the systematic evaluation of RMC-7977 in a wide range of preclinical models of PDAC.
Erica Kollmann
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
2
Jan
1
Feb
2
1
Mar
4
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Revolution Medicines Inc
Sector
Health Care
Industry
Biotechnology
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RVMD
IMVT

FAQ

Q

How do I buy Revolution Medicines (RVMD) stock?

A

You can purchase shares of Revolution Medicines (NASDAQ: RVMD) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Revolution Medicines's (RVMD) competitors?

A

Other companies in Revolution Medicines’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Ionis Pharmaceuticals (NASDAQ:IONS).

Q

What is the target price for Revolution Medicines (RVMD) stock?

A

The latest price target for Revolution Medicines (NASDAQ: RVMD) was reported by Oppenheimer on Friday, April 12, 2024. The analyst firm set a price target for 45.00 expecting RVMD to rise to within 12 months (a possible 22.97% upside). 26 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Revolution Medicines (RVMD)?

A

The stock price for Revolution Medicines (NASDAQ: RVMD) is $36.595 last updated Today at April 23, 2024 at 3:34 PM EDT.

Q

Does Revolution Medicines (RVMD) pay a dividend?

A

There are no upcoming dividends for Revolution Medicines.

Q

When is Revolution Medicines (NASDAQ:RVMD) reporting earnings?

A

Revolution Medicines’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is Revolution Medicines (RVMD) going to split?

A

There is no upcoming split for Revolution Medicines.

Q

What sector and industry does Revolution Medicines (RVMD) operate in?

A

Revolution Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch